CD70-KOMBINATIONSTHERAPIE

European patent · EP3740504 · In force

Register entry

Publication number
EP3740504
Application number
EP19702014
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Corrected
Filed
Jan 16, 2019
Published
Nov 25, 2020
Granted
Jul 19, 2023
Protection ends at the latest
Jan 15, 2039
Next annual fee due
Jan 31, 2027
IPC classes
C07K 16/28 (2006.01)
A61P 35/00 (2006.01)
A61K 39/395 (2006.01)
Priority
GB 201800649 16.01.2018
PCT application
PCT/EP2019/051058 16.01.2019
PCT publication
WO2019/141732 25.07.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. May 29, 2024

    Change

    Published in Swissreg on 29.05.2024

  4. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  5. Oct 25, 2023

    Change

    Published in Swissreg on 25.10.2023

  6. Aug 18, 2023

    Agent entered

    Representative
    Kirker & Cie SA, Rue de Genève 122, CP 153, 1226 Genève-Thônex

    Published in Swissreg on 18.08.2023

  7. Jul 19, 2023

    Granted

    Published in Swissreg on 19.07.2023

Parties

Holder

Argenx BVBA

Industriepark Zwijnaarde 7 Building C, 9052 Gent, BE

Agent

Kirker & Cie SA

Rue de Genève 122 CP 153, 1226 Genève-Thônex

Inventor

ZABROCKI, Piotr

9052 Zwijnaarde, BE

VAN ROMPAEY, Luc

9052 Zwijnaarde, BE

DELAHAYE, Tim

9052 Zwijnaarde, BE

MOSHIR, Mahan

9052 Zwijnaarde, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.